奥扎基手术是否有未来作为一种新型的大动脉置换手术方法? 一个系统的审查和元分析
Ahmed K Awad1,2, Ramadan A Farahat3, Eman Reda Gad4
1Faculty of Medicine.
Annals of medicine and surgery (2012)
|September 4, 2023
概括
奥扎基手术,即心周大动脉,提供了一种安全有效的手术选择. 这一元分析显示,手术时间缩短,住院时间缩短,表明它在治疗大动脉膜疾病中的有效性.
科学领域:
- 心血管外科心血管外科
- 生物材料科学 生物材料科学
背景情况:
- 奥扎基手术是2014年推出的新型心周大动脉,旨在缓解与传统门相关的慢性炎症和退行.
- 这种技术旨在减少自身免疫排斥和长期门衰竭的风险.
研究的目的:
- 评估奥扎基技术在治疗大动脉膜疾病方面的安全性和有效性.
- 综合现有证据,以分析患者在奥扎基手术后的治疗结果.
主要方法:
- 在主要数据库 (PubMed,Cochrane Library,Scopus,Web of Science) 进行了系统的文献搜索,截至2022年2月.
- 使用随机效应元分析模型,将包含的研究数据汇集在一起.
- 使用OpenMeta分析软件进行数据分析.
主要成果:
- 该分析包括来自21项研究的2863名患者.
- 奥扎基技术在心肺绕道 (148分钟) 和大动脉十字时间 (112.46分钟) 中显示出统计学上显著的减少.
- 在重新手术 (0.011) 和ICU/住院期间 (分别为2.06天和8.16天) 观察到低风险.
结论:
- 奥扎基手术是对大动脉膜疾病的一种安全的手术方法.
- 它与更短的手术时间和缩短的术后恢复期有关.
- 该技术显示不良事件的风险很低,包括转换为大动脉替换和重新操作.
更多相关视频
相关概念视频
Aortic Regurgitation III: Medical Management
25
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
25
Aortic Regurgitation I: Introduction
12
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
12
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Valve Prolapse II: Assessment and Management
21
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
21
Mitral Stenosis I: Introduction
16
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
16
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18


